Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kohn

Showing results (161-170 of 369) with videos related to

Pageof 37
Sort By:
Lancet (London, England)|April 29, 2014
Ovarian cancerGordon C Jayson, Elise C Kohn, Henry C Kitchener, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 18, 2013
Dynamic high-resolution ultrasound in vivo imaging of hyaluronic acid filler injectionJocelyne C Kohn, Alice S Goh, Joseph L Lin, et al.
Toxicology and Applied Pharmacology|October 17, 2001
A physiologically based pharmacokinetic model for inhalation and intravenous administration of naphthalene in rats and miceB A Willems, R L Melnick, M C Kohn, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1991
The antiproliferative and antimetastatic compound L651582 inhibits muscarinic acetylcholine receptor-stimulated calcium influx and arachidonic acid releaseC C Felder, A L Ma, L A Liotta, et al.
Cancer Treatment and Research|September 19, 2009
Cell adhesion in ovarian cancerWafic M Elmasri, Giovanna Casagrande, Ebony Hoskins, et al.
Frontiers in Oncology|March 12, 2014
Beyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid TumorsCiara C O'Sullivan, Dominic H Moon, Elise C Kohn, et al.
Toxicology and Applied Pharmacology|January 1, 1996
A mechanistic model of effects of dioxin on thyroid hormones in the ratM C Kohn, C H Sewall, G W Lucier, et al.
Regulatory Toxicology and Pharmacology : RTP|December 11, 2002
Impact of physiologically based pharmacokinetic modeling on benchmark dose calculations for TCDD-induced biochemical responsesAmy H Kim, Michael C Kohn, Christopher J Portier, et al.
Disease Markers|December 7, 2007
Proteomics as a tool for biomarker discoveryElise C Kohn, Nilofer Azad, Christina Annunziata, et al.
Toxicology and Applied Pharmacology|February 18, 1998
Regenerative hyperplasia is not required for liver tumor induction in female B6C3F1 mice exposed to trihalomethanesR L Melnick, M C Kohn, J K Dunnick, et al.
Pageof 37

Showing results (161-170 of 369) with videos related to

Sort By:
Pageof 37
Lancet (London, England)|April 29, 2014
Ovarian cancerGordon C Jayson, Elise C Kohn, Henry C Kitchener, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 18, 2013
Dynamic high-resolution ultrasound in vivo imaging of hyaluronic acid filler injectionJocelyne C Kohn, Alice S Goh, Joseph L Lin, et al.
Toxicology and Applied Pharmacology|October 17, 2001
A physiologically based pharmacokinetic model for inhalation and intravenous administration of naphthalene in rats and miceB A Willems, R L Melnick, M C Kohn, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1991
The antiproliferative and antimetastatic compound L651582 inhibits muscarinic acetylcholine receptor-stimulated calcium influx and arachidonic acid releaseC C Felder, A L Ma, L A Liotta, et al.
Cancer Treatment and Research|September 19, 2009
Cell adhesion in ovarian cancerWafic M Elmasri, Giovanna Casagrande, Ebony Hoskins, et al.
Frontiers in Oncology|March 12, 2014
Beyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid TumorsCiara C O'Sullivan, Dominic H Moon, Elise C Kohn, et al.
Toxicology and Applied Pharmacology|January 1, 1996
A mechanistic model of effects of dioxin on thyroid hormones in the ratM C Kohn, C H Sewall, G W Lucier, et al.
Regulatory Toxicology and Pharmacology : RTP|December 11, 2002
Impact of physiologically based pharmacokinetic modeling on benchmark dose calculations for TCDD-induced biochemical responsesAmy H Kim, Michael C Kohn, Christopher J Portier, et al.
Disease Markers|December 7, 2007
Proteomics as a tool for biomarker discoveryElise C Kohn, Nilofer Azad, Christina Annunziata, et al.
Toxicology and Applied Pharmacology|February 18, 1998
Regenerative hyperplasia is not required for liver tumor induction in female B6C3F1 mice exposed to trihalomethanesR L Melnick, M C Kohn, J K Dunnick, et al.
Pageof 37